How early-life gut microbes shape immune T cell development

Early life regulation of microbiota specific thymic T cell development

NIH-funded research Utah State Higher Education System--University of Utah · NIH-11224087

This research explores whether early-life gut microbes help train immune T cells in the thymus so babies and people at risk for allergies or autoimmune conditions are better protected.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUtah State Higher Education System--University of Utah NIH-funded
Lab location1 site (Salt Lake City, United States)
Project IDNIH-11224087 on NIH RePORTER

What this research studies

This work looks at how microbes a baby encounters early in life can send signals from the gut to the thymus, the organ that helps train immune T cells. Using mouse models, researchers will track intestinal immune cells (dendritic cells) that carry microbial material to the thymus and identify the microbial molecules and thymic signals involved. They will manipulate how microbes attach to gut cells and test whether those changes alter DC migration and expansion of microbe-specific T cells. The team will also check whether these microbe-driven T cells help protect against infections or allergic responses.

Who could benefit from this research

Good fit: People most relevant to this research include infants and young children and individuals with a personal or family history of asthma, allergies, or autoimmune disease.

Not a fit: Patients with conditions that are unrelated to immune development or not linked to early-life microbiota are unlikely to receive direct benefit from this work.

Why it matters

Potential benefit: If successful, the findings could point to new ways to prevent or reduce childhood asthma, allergies, or related autoimmune problems by promoting beneficial early-life gut microbes or their signals.

How similar studies have performed: Prior human and animal studies link richer early-life microbiota with lower allergy risk and show microbes shape immune development, but the specific gut-to-thymus migration mechanism and exact microbial signals are newly described and remain under study.

Where this research is happening

Salt Lake City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Autoimmune Diseases
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.